MONTANOVA CAPITAL, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001569064

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q3 2025 · 92 positions · Total reported value $3.87B · Top-10 concentration 42.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 47.3% · 21 new · 17 cut · 14 exited

Active Share (vs S&P 500): 88.7% · vs QQQ: 90.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +26.5% · vs SPY +11.7% · Prev Value $3.92B — last quarter positions weighted by this quarter price moves · ranking

In its Q3 2025 13F filing, MONTANOVA CAPITAL, LLC disclosed 92 equity positions with a combined reported value of $3.87B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 42.0% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2025 were SPY ($532.94M), ARQT ($197.51M), BNTC ($138.57M). By sector, the heaviest allocations are Health Care 40.2%, Technology 17.6%. Versus the prior quarter, allocation shifted toward Health Care (+1.2pp), Industrials (+0.7pp) and away from Consumer Discretionary (-0.9pp), Other (-2.5pp).

Versus the prior quarter, MONTANOVA CAPITAL, LLC opened 21 new positions, trimmed 17 and fully exited 14, a turnover rate of 47.3% of positions. The portfolio's overlap with the prior quarter was 78% of names.

The largest new positions opened in Q3 2025 were XBI ($50.10M), MSOS ($34.33M), RNAM ($32.68M).

Of the 14 positions fully exited versus the prior quarter, the largest were IWM ($151.59M), GEHC ($39.43M), DDOG ($24.02M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2025)

  • XBI SPDR SERIES TRUST · $50.10M
  • MSOS ADVISORSHARES TR · $34.33M
  • RNAM AVIDITY BIOSCIENCES INC · $32.68M
  • CRM SALESFORCE INC · $29.68M
  • KDP KEURIG DR PEPPER INC · $25.51M
  • MRVL Marvell Technology Inc · $22.89M
  • NOW SERVICENOW INC · $20.25M
  • SNOW SNOWFLAKE INC · $20.12M

Fully Exited (vs previous quarter)

  • IWM ISHARES TR · prev qtr: $151.59M
  • GEHC GE HEALTHCARE TECHNOLOGIES I · prev qtr: $39.43M
  • DDOG DATADOG INC · prev qtr: $24.02M
  • MRNA MODERNA INC · prev qtr: $14.27M
  • KYMR KYMERA THERAPEUTICS INC · prev qtr: $12.00M
  • TSHA TAYSHA GENE THERAPIES INC · prev qtr: $7.43M
  • WING WINGSTOP INC · prev qtr: $1.33M
  • OS ONESTREAM INC · prev qtr: $936.16K

Insider Transactions (Form 4)

Latest MONTANOVA CAPITAL, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-08-20 Opt exercise Veradermics, Inc 151,000 — SEC filing
2026-08-20 Opt exercise Veradermics, Inc 149,000 — SEC filing
2026-08-19 Sell Veradermics, Inc 59,399 $107.25 SEC filing
2026-08-19 Sell Veradermics, Inc 690,601 $107.25 SEC filing

All insider transactions →

Fund Profile

Montanova Capital, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 96 positions worth $5.47B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-79962 (status: Approved), registered 2014-06-26
  • Regulatory AUM (Form ADV): $7.87B as of 2026-07-01
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 3 hedge funds
  • Website: montanova.com

Portfolio Structure

  • 96 positions · $5.47B reported value (Q2 2026)
  • Top 10 holdings = 49.1% of reported value
  • Largest position: SPY (STATE STR SPDR S&P 500 ETF T) at 13.0%
  • Average position size: $56.96M

Sector Tilt

  • Health Care 50.9%
  • Information Technology 14.5%
  • Consumer Discretionary 8.3%
  • (classified holdings cover 83% of value)

Quarterly Activity

  • Q2 2026: 21 new, 26 added, 17 reduced, 14 exited
  • 32 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 40.2%
Technology 17.6%
Financials 4.8%
Other 23.4%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 800.00K $532.94M 13.78%
13.78%
Add
2 10.48M $197.51M 5.11%
5.11%
Reduce
3 9.88M $138.57M 3.58%
3.58%
Hold
4 170.97K $125.56M 3.25%
3.25%
Add
5 3.82M $124.51M 3.22%
3.22%
Add
6 8.28M $121.72M 3.15%
3.15%
Reduce
7 12.03M $102.50M 2.65%
2.65%
Hold
8 1.46M $96.50M 2.50%
2.50%
Add
9 310.26K $93.33M 2.41%
2.41%
Hold
10 483.54K $90.22M 2.33%
2.33%
Reduce
11 6.19M $88.18M 2.28%
2.28%
Reduce
12 5.62M $84.36M 2.18%
2.18%
Hold
13 2.13M $80.85M 2.09%
2.09%
Add
14 197.31K $79.95M 2.07%
2.07%
Add
15 277.20K $77.42M 2.00%
2.00%
Reduce
16 8.12M $71.83M 1.86%
1.86%
Hold
17 306.26K $68.78M 1.78%
1.78%
Add
18 3.70M $68.33M 1.77%
1.77%
Add
19 2.88M $65.13M 1.68%
1.68%
Hold
20 398.80K $64.52M 1.67%
1.67%
Hold
21 226.32K $63.65M 1.65%
1.65%
Reduce
22 2.02M $60.73M 1.57%
1.57%
Reduce
23 1.16M $59.86M 1.55%
1.55%
Add
24 4.77M $58.08M 1.50%
1.50%
Reduce
25 431.26K $57.47M 1.49%
1.49%
Add
26 109.45K $56.69M 1.47%
1.47%
Add
27 822.40K $51.56M 1.33%
1.33%
Add
28 238.77K $50.76M 1.31%
1.31%
Add
29 255.80K $50.71M 1.31%
1.31%
Add
30 3.69M $50.17M 1.30%
1.30%
Hold
31 500.00K $50.10M 1.30%
1.30%
New
32 5.38M $49.51M 1.28%
1.28%
Add
33 14.10M $49.35M 1.28%
1.28%
Add
34 218.55K $47.99M 1.24%
1.24%
Reduce
35 91.25K $40.58M 1.05%
1.05%
Reduce
36 353.56K $34.52M 0.89%
0.89%
Hold
37 7.17M $34.33M 0.89%
0.89%
New
38 96.22K $33.22M 0.86%
0.86%
Add
39 750.00K $32.68M 0.84%
0.84%
New
40 14.50M $31.61M 0.82%
0.82%
Hold
41 217.78K $31.36M 0.81%
0.81%
Reduce
42 12.34M $29.87M 0.77%
0.77%
Hold
43 125.25K $29.68M 0.77%
0.77%
New
44 128.29K $28.51M 0.74%
0.74%
Reduce
45 4.37M $27.02M 0.70%
0.70%
Hold
46 1.00M $25.51M 0.66%
0.66%
New
47 3.36M $24.90M 0.64%
0.64%
Hold
48 132.79K $24.62M 0.64%
0.64%
Hold
49 5.47M $23.70M 0.61%
0.61%
Add
50 168.19K $23.56M 0.61%
0.61%
Add

FAQ

What did MONTANOVA CAPITAL, LLC buy in 2025-Q3?

In its 2025-Q3 13F filing, MONTANOVA CAPITAL, LLC reported 92 equity positions worth $3.87B in aggregate; its largest disclosed positions were SPY ($532.94M), ARQT ($197.51M), BNTC ($138.57M).

How large is MONTANOVA CAPITAL, LLC's portfolio?

MONTANOVA CAPITAL, LLC reported $3.87B of long equity holdings across 92 positions as of 2025-Q3. Top-10 holdings account for 42.0% of reported value.

What is MONTANOVA CAPITAL, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/montanova-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →